Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 122

1.

Applications of DNA microarrays in biology.

Stoughton RB.

Annu Rev Biochem. 2005;74:53-82. Review.

PMID:
15952881
2.

How molecular profiling is transforming drug discovery.

Stoughton RB.

Discov Med. 2005 Jun;5(27):247-52.

3.

How molecular profiling could revolutionize drug discovery.

Stoughton RB, Friend SH.

Nat Rev Drug Discov. 2005 Apr;4(4):345-50. Review.

PMID:
15789121
4.

Integrated genomic and proteomic analyses of gene expression in Mammalian cells.

Tian Q, Stepaniants SB, Mao M, Weng L, Feetham MC, Doyle MJ, Yi EC, Dai H, Thorsson V, Eng J, Goodlett D, Berger JP, Gunter B, Linseley PS, Stoughton RB, Aebersold R, Collins SJ, Hanlon WA, Hood LE.

Mol Cell Proteomics. 2004 Oct;3(10):960-9. Epub 2004 Jul 6.

5.

Effects of atmospheric ozone on microarray data quality.

Fare TL, Coffey EM, Dai H, He YD, Kessler DA, Kilian KA, Koch JE, LeProust E, Marton MJ, Meyer MR, Stoughton RB, Tokiwa GY, Wang Y.

Anal Chem. 2003 Sep 1;75(17):4672-5.

PMID:
14632079
6.

Microarray standard data set and figures of merit for comparing data processing methods and experiment designs.

He YD, Dai H, Schadt EE, Cavet G, Edwards SW, Stepaniants SB, Duenwald S, Kleinhanz R, Jones AR, Shoemaker DD, Stoughton RB.

Bioinformatics. 2003 May 22;19(8):956-65.

PMID:
12761058
7.

Genetics of gene expression surveyed in maize, mouse and man.

Schadt EE, Monks SA, Drake TA, Lusis AJ, Che N, Colinayo V, Ruff TG, Milligan SB, Lamb JR, Cavet G, Linsley PS, Mao M, Stoughton RB, Friend SH.

Nature. 2003 Mar 20;422(6929):297-302.

PMID:
12646919
8.

The magic of microarrays.

Friend SH, Stoughton RB.

Sci Am. 2002 Feb;286(2):44-9, 53. No abstract available.

PMID:
11828700
9.

The vasoconstrictor assay in bioequivalence testing: practical concerns and recent developments.

Stoughton RB.

Int J Dermatol. 1992 Oct;31 Suppl 1:26-8. Review.

PMID:
1428464
10.

Relation of application time to bioactivity of a potent topical glucocorticoid formulation.

Stoughton RB, Wullich K.

J Am Acad Dermatol. 1990 Jun;22(6 Pt 1):1038-41.

PMID:
2370328
11.
12.

In vitro and in vivo cutaneous penetration and antifungal activity of naftifine.

Stoughton RB, Sefton J, Zeleznick L.

Cutis. 1989 Oct;44(4):333-5.

PMID:
2805810
13.

Ciclopirox olamine lotion 1%: bioequivalence to ciclopirox olamine cream 1% and clinical efficacy in tinea pedis.

Aly R, Maibach HI, Bagatell FK, Dittmar W, Hänel H, Falanga V, Leyden JJ, Roth HL, Stoughton RB, Willis I, et al.

Clin Ther. 1989 May-Jun;11(3):290-303.

PMID:
2663159
14.

Percutaneous absorption of drugs.

Stoughton RB.

Annu Rev Pharmacol Toxicol. 1989;29:55-69. Review.

PMID:
2658778
15.

Adrenal suppression following low-dose topical clobetasol propionate.

Stoughton RB.

J R Soc Med. 1988 May;81(5):308. No abstract available.

16.

Erythromycin 2 percent gel in the treatment of acne vulgaris.

Pochi PE, Bagatell FK, Ellis CN, Stoughton RB, Whitmore CG, Saatjian GD, Sefton J.

Cutis. 1988 Feb;41(2):132-6.

PMID:
2964344
17.

Are generic topical glucocorticosteroids equivalent to the brand name?

Stoughton RB.

J Am Acad Dermatol. 1988 Jan;18(1 Pt 1):138-9. No abstract available.

PMID:
3346396
18.

Are generic formulations equivalent to trade name topical glucocorticoids?

Stoughton RB.

Arch Dermatol. 1987 Oct;123(10):1312-4.

PMID:
3662563
19.
20.
21.

Correlation of the vasoconstriction assay and clinical activity in psoriasis.

Cornell RC, Stoughton RB.

Arch Dermatol. 1985 Jan;121(1):63-7.

PMID:
3881088
22.

Psoriasis.

Stoughton RB.

West J Med. 1983 Aug;139(2):216. No abstract available.

23.

Enhanced percutaneous penetration with 1-dodecylazacycloheptan-2-one.

Stoughton RB.

Arch Dermatol. 1982 Jul;118(7):474-7.

PMID:
7092271
24.

Clinical use of a selective culture medium for wild and antibiotic-resistant Propionibacterium acnes.

Marino C, Stoughton RB.

J Am Acad Dermatol. 1982 May;6(5):902-8. No abstract available.

PMID:
6212602
25.

Topical or systemic antibiotics for acne.

Stoughton RB.

Int J Dermatol. 1981 Nov;20(9):592-3. No abstract available.

PMID:
6458571
26.

Topical clindamycin therapy for acne vulgaris. A cooperative clinical study.

Becker LE, Bergstresser PR, Whiting DA, Clendenning WE, Dobson RL, Jordan WP, Abell E, LeZotte LA, Pochi PE, Shupack JL, Sigafoes RB, Stoughton RB, Voorhees JJ.

Arch Dermatol. 1981 Aug;117(8):482-5.

PMID:
6455095
27.
28.

Topical drug effects on normal and proliferating epidermal cell models.

Lowe NJ, Stoughton RB, McCullough JL, Weinstein GD.

Arch Dermatol. 1981 Jul;117(7):394-8.

PMID:
7259217
29.

A clinical screening program for topical chemotherapeutic drugs in psoriasis.

Weinstein GD, McCullough JL, Eaglstein WH, Golub A, Cornell RC, Stoughton RB, Clendenning W, Zackheim H, Maibach H, Kulp KR, King L, Baden HP, Taylor JS, Deneau DD.

Arch Dermatol. 1981 Jul;117(7):388-93.

PMID:
6789777
30.
31.

What's new.

Stoughton RB.

J Am Acad Dermatol. 1980 May;2(5):411-6. Review. No abstract available.

PMID:
6155388
33.

Use of glucocorticosteroids in psoriasis.

Cornell RC, Stoughton RB.

Pharmacol Ther. 1980;11(3):497-508. Review. No abstract available.

PMID:
7003606
34.

"What's new".

Stoughton RB.

J Am Acad Dermatol. 1979 Jul;1(1):70-4. Review. No abstract available.

PMID:
387826
35.

Laboratory induction and clinical occurrence of combined clindamycin and erythromycin resistance in Corynebacterium acnes.

Crawford WW, Crawford IP, Stoughton RB, Cornell RC.

J Invest Dermatol. 1979 Apr;72(4):187-90.

36.

Topical antibiotics for acne vulgaris. Current usage.

Stoughton RB.

Arch Dermatol. 1979 Apr;115(4):486-9. No abstract available.

PMID:
155425
37.

Dermatitis from purified sea algae toxin (debromoaplysiatoxin).

Solomon AE, Stoughton RB.

Arch Dermatol. 1978 Sep;114(9):1333-5.

PMID:
686747
38.

Suppression of epidermal proliferation by ultraviolet light, coal tar and anthralin.

Walter JF, Stoughton RB, DeQuoy PR.

Br J Dermatol. 1978 Jul;99(1):89-96.

PMID:
678469
39.

Crude coal tar plus near ultraviolet light suppresses DNA synthesis in epidermis.

Stoughton RB, DeQuoy P, Walter JF.

Arch Dermatol. 1978 Jan;114(1):43-5.

PMID:
619781
40.
41.
42.
43.

Anemia of azaribine in the treatment of psoriasis.

Cornell RC, Milstein HG, Fox RM, Stoughton RB.

Arch Dermatol. 1976 Dec;112(12):1717-23.

PMID:
1036874
44.

Acute tolerance to effects of topical glucocorticosteroids.

Vivier AD, Stoughton RB.

Br J Dermatol. 1976 Mar;94 suppl 12:25-32.

PMID:
1268076
45.

Topical clindamycin in the control of acne vulgaris.

Stoughton RB, Resh W.

Cutis. 1976 Mar;17(3):551-4. No abstract available.

PMID:
138549
46.

Inhibition of induction of human contact sensitization by topical glucocorticosteroids.

Burrows WM, Stoughton RB.

Arch Dermatol. 1976 Feb;112(2):175-8.

PMID:
962352
48.

An animal model for screening drugs for antipsoriatic properties using hydroxyapatite to isolate DNA rapidly from the epidermis.

du Vivier A, Bible R Jr, Mikuriya RK, Stoughton RB.

Br J Dermatol. 1976 Jan;94(1):1-6.

PMID:
1252332
49.

Penetration of drugs through the skin.

Stoughton RB.

Dermatologica. 1976;152 Suppl 1:27-36.

PMID:
133842
50.

Supplemental Content

Loading ...
Support Center